Anika Therapeutics (ANIK) Q4 2024 Earnings

31OctConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.25
-0.11
0.03
0.17

Details

Expected EPS
0.09
Actual EPS
-0.25
Surprise EPS
-0.34
Surprise Percent
+377.78%

Description

Anika Therapeutics (ANIK) has reported earnings of -0.25 per share for Q4 2024.

0 Comments

Share your thoughts